SciELO - Scientific Electronic Library Online

 
vol.34 número2Práticas recomendadas para triagem e prevenção de complicações em sobreviventes de longo prazo após transplante de células hematopoéticasPhiladelphia-negative chronic myeloproliferative neoplasms índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

Compartilhar


Revista Brasileira de Hematologia e Hemoterapia

versão impressa ISSN 1516-8484

Resumo

BASSI, Sarah Cristina  e  REGO, Eduardo Magalhães. Molecular basis for the diagnosis and treatment of acute promyelocytic leukemia. Rev. Bras. Hematol. Hemoter. [online]. 2012, vol.34, n.2, pp.134-139. ISSN 1516-8484.  https://doi.org/10.5581/1516-8484.20120033.

Acute promyelocytic leukemia is characterized by gene rearrangements that always involve the retinoic acid receptor alpha on chromosome 15. In the majority of patients t(15;17) is detected, which generates the promyelocytic leukemia gene/retinoic acid receptor alpha rearrangement. This rearrangement interacts with several proteins, including the native promyelocytic leukemia gene, thus causing its delocalization from the nuclear bodies, impairing its function. The immunofluorescence staining technique using the anti-PML antibody may be used to provide a rapid diagnosis and to immediately start therapy using all-trans retinoic acid. The experience of the International Consortium on Acute Promyelocytic Leukemia has demonstrated that early mortality was significantly reduced by adopting the immunofluorescence technique. All-trans retinoic acid combined with chemotherapy is the standard therapy; this promotes complete remission rates greater than 90% and cure rates of nearly 80%. However, early mortality is still an important limitation and hematologists must be aware of the importance of treating newly diagnosed acute promyelocytic leukemia as a medical emergency.

Palavras-chave : leukemia, promyelocytic, acute [epidemilogy]; leukemia, myeloid, acute [epidemiology]; leukemia, promyelocytic, acute [diagnosis]; leukemia, myeloid, acute [diagnosis]; leukemia, promyelocytic, acute [drug therapy]; leukemia, myeloid, acute [drug therapy].

        · texto em Inglês     · Inglês ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons